704 related articles for article (PubMed ID: 29429624)
21. microRNA-33 Regulates Macrophage Autophagy in Atherosclerosis.
Ouimet M; Ediriweera H; Afonso MS; Ramkhelawon B; Singaravelu R; Liao X; Bandler RC; Rahman K; Fisher EA; Rayner KJ; Pezacki JP; Tabas I; Moore KJ
Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1058-1067. PubMed ID: 28428217
[TBL] [Abstract][Full Text] [Related]
22. Pathophysiological mechanisms and therapeutic potentials of macrophages in non-alcoholic steatohepatitis.
Wu R; Nakatsu G; Zhang X; Yu J
Expert Opin Ther Targets; 2016; 20(5):615-26. PubMed ID: 26609894
[TBL] [Abstract][Full Text] [Related]
23. Macrophage Function in the Pathogenesis of Non-alcoholic Fatty Liver Disease: The Mac Attack.
Oates JR; McKell MC; Moreno-Fernandez ME; Damen MSMA; Deepe GS; Qualls JE; Divanovic S
Front Immunol; 2019; 10():2893. PubMed ID: 31921154
[TBL] [Abstract][Full Text] [Related]
24. Nuclear receptors in macrophage biology: at the crossroads of lipid metabolism and inflammation.
Castrillo A; Tontonoz P
Annu Rev Cell Dev Biol; 2004; 20():455-80. PubMed ID: 15473848
[TBL] [Abstract][Full Text] [Related]
25. Cholesterol and bile acid-mediated regulation of autophagy in fatty liver diseases and atherosclerosis.
Wang Y; Ding WX; Li T
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Jul; 1863(7):726-733. PubMed ID: 29653253
[TBL] [Abstract][Full Text] [Related]
26. Eyeballing cholesterol efflux and macrophage function in disease pathogenesis.
Sene A; Apte RS
Trends Endocrinol Metab; 2014 Mar; 25(3):107-14. PubMed ID: 24252662
[TBL] [Abstract][Full Text] [Related]
27. Omic studies reveal the pathogenic lipid droplet proteins in non-alcoholic fatty liver disease.
Zhang X; Wang Y; Liu P
Protein Cell; 2017 Jan; 8(1):4-13. PubMed ID: 27757845
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-10 protects against atherosclerosis by modulating multiple atherogenic macrophage function.
Han X; Boisvert WA
Thromb Haemost; 2015 Mar; 113(3):505-12. PubMed ID: 25373619
[TBL] [Abstract][Full Text] [Related]
29. Foam Cells: One Size Doesn't Fit All.
Guerrini V; Gennaro ML
Trends Immunol; 2019 Dec; 40(12):1163-1179. PubMed ID: 31732284
[TBL] [Abstract][Full Text] [Related]
30. Tim-4 Inhibits NLRP3 Inflammasome via the LKB1/AMPKα Pathway in Macrophages.
Liu W; Bai F; Wang H; Liang Y; Du X; Liu C; Cai D; Peng J; Zhong G; Liang X; Ma C; Gao L
J Immunol; 2019 Aug; 203(4):990-1000. PubMed ID: 31263038
[TBL] [Abstract][Full Text] [Related]
31. Endoplasmic Reticulum Stress Affects Lipid Metabolism in Atherosclerosis Via CHOP Activation and Over-Expression of miR-33.
Sun Y; Zhang D; Liu X; Li X; Liu F; Yu Y; Jia S; Zhou Y; Zhao Y
Cell Physiol Biochem; 2018; 48(5):1995-2010. PubMed ID: 30092598
[TBL] [Abstract][Full Text] [Related]
32. Nuclear receptor mediated mechanisms of macrophage cholesterol metabolism.
Nagy ZS; Czimmerer Z; Nagy L
Mol Cell Endocrinol; 2013 Apr; 368(1-2):85-98. PubMed ID: 22546548
[TBL] [Abstract][Full Text] [Related]
33. Emerging Molecular Targets for Treatment of Nonalcoholic Fatty Liver Disease.
Chen Z; Yu Y; Cai J; Li H
Trends Endocrinol Metab; 2019 Dec; 30(12):903-914. PubMed ID: 31597607
[TBL] [Abstract][Full Text] [Related]
34. Lipid homeostasis in macrophages - implications for atherosclerosis.
Schmitz G; Grandl M
Rev Physiol Biochem Pharmacol; 2008; 160():93-125. PubMed ID: 18425439
[TBL] [Abstract][Full Text] [Related]
35. Nuclear receptors in macrophages: a link between metabolism and inflammation.
Szanto A; Roszer T
FEBS Lett; 2008 Jan; 582(1):106-16. PubMed ID: 18022390
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of mitochondrial cholesterol delivery protein, StAR, decreases intracellular lipids and inflammatory factors secretion in macrophages.
Ning Y; Bai Q; Lu H; Li X; Pandak WM; Zhao F; Chen S; Ren S; Yin L
Atherosclerosis; 2009 May; 204(1):114-20. PubMed ID: 18945429
[TBL] [Abstract][Full Text] [Related]
37. Macrophage-mediated cholesterol handling in atherosclerosis.
Chistiakov DA; Bobryshev YV; Orekhov AN
J Cell Mol Med; 2016 Jan; 20(1):17-28. PubMed ID: 26493158
[TBL] [Abstract][Full Text] [Related]
38. Innate immunity, macrophage activation, and atherosclerosis.
Yan ZQ; Hansson GK
Immunol Rev; 2007 Oct; 219():187-203. PubMed ID: 17850490
[TBL] [Abstract][Full Text] [Related]
39. Innate immune regulatory networks in hepatic lipid metabolism.
Bai L; Li H
J Mol Med (Berl); 2019 May; 97(5):593-604. PubMed ID: 30891617
[TBL] [Abstract][Full Text] [Related]
40. Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease.
Rosso C; Kazankov K; Younes R; Esmaili S; Marietti M; Sacco M; Carli F; Gaggini M; Salomone F; Møller HJ; Abate ML; Vilstrup H; Gastaldelli A; George J; Grønbæk H; Bugianesi E
J Hepatol; 2019 Nov; 71(5):1012-1021. PubMed ID: 31301321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
